Type 2 diabetes Trials in Beijing, China
Conditions / Type 2 diabetes / Beijing, China
Type 2 diabetes is a medical condition with active clinical research programs worldwide.
80 total trials for this combination
Showing top 10 of 80 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05362058 | A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time | COMPLETED | PHASE3 |
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes | ACTIVE_NOT_RECRUITING | — |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone | COMPLETED | — |
| NCT06045221 | A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin | COMPLETED | PHASE3 |
| NCT06972472 | A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes | RECRUITING | PHASE3 |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone | COMPLETED | — |
| NCT05872620 | A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes | COMPLETED | PHASE3 |
| NCT06184568 | A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and Obesity | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06993792 | A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes | ACTIVE_NOT_RECRUITING | — |
| NCT05971940 | A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone | COMPLETED | — |